Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibroblast-pneumonocyte factor.

B T Smith1, M Post

  • 1Department of Paediatrics, University of Toronto, Ontario, Canada.

The American Journal of Physiology
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the proximity of alcohol outlets to schools after the introduction of convenience store alcohol sales in Ontario, Canada: A descriptive study.

Public health·2026
Same author

Invited review: Global census on the development and implementation of direct genetic selection for enteric methane emissions in dairy cattle.

Journal of dairy science·2026
Same author

Incidence of severe COVID-19 among 1.2 million workers in Ontario, Canada.

Occupational medicine (Oxford, England)·2025
Same author

Breeding for sustainability: Development of an index to reduce greenhouse gas in dairy cattle.

Animal : an international journal of animal bioscience·2025
Same author

Complicated Case of Obstetrics.

Atlanta medical and surgical journal·2022
Same author

[Adolescents with concurrent ADHD and substance use disorder; international consensus].

Tijdschrift voor psychiatrie·2022
Same journal

Blood coagulation in fish.

The American journal of physiology·2011
Same journal

Renal tubular reabsorption, metabolic utilization and isomeric fractionation of lactic acid in the dog.

The American journal of physiology·2010
Same journal

The inactivation of placental toxin by human serum.

The American journal of physiology·2010
Same journal

Adrenal function following ovariectomy in the rat.

The American journal of physiology·2010
Same journal

Capillary permeability; perfusion of frog and guinea pig hind limbs.

The American journal of physiology·2010
Same journal

Evaluation of protective measures against sunburn.

The American journal of physiology·2010
See all related articles

Fibroblast-pneumonocyte factor (FPF) enhances fetal lung maturation by promoting alveolar type II cell differentiation for surfactant production. FPF offers potential clinical advantages over maternal glucocorticoid therapy for lung development.

Area of Science:

  • Pulmonology
  • Developmental Biology
  • Endocrinology

Background:

  • Alveolar type II cells are crucial for lung function, producing surfactant.
  • Fetal lung development involves complex cellular differentiation processes.
  • Glucocorticoids regulate fetal lung maturation, but with limitations.

Purpose of the Study:

  • To review the role of fibroblast-pneumonocyte factor (FPF) in fetal lung maturation.
  • To examine FPF's mechanism in type II cell differentiation and surfactant production.
  • To explore clinical applications of FPF for regulating lung development.

Main Methods:

  • Review of existing literature on FPF, type II cells, and lung maturation.
  • Analysis of FPF production by fetal lung fibroblasts.

Related Experiment Videos

  • Examination of FPF's effects on type II cell differentiation.

    • Main Results:

    • FPF is an organ-specific factor produced by fetal lung fibroblasts.
    • FPF enhances the differentiation of alveolar type II cells, timing surfactant production.
    • Evidence supports a physiological role for FPF in lung development.

    Conclusions:

    • FPF plays a key role in timing the acquisition of the type II cell phenotype.
    • FPF may offer advantages over maternal glucocorticoid therapy, including faster effects.
    • FPF could bypass glucocorticoid resistance in male fetuses and infants of diabetic mothers.